• Axsome Therapeutics average return on investment for 2023 was -65.25, a 56.3% increase from 2022.
• Axsome Therapeutics average return on investment for 2022 was -149.3, a 68.78% decline from 2021.
• Axsome Therapeutics average return on investment for 2021 was -88.46, a 34.25% increase from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.